Delivery Order SPE2DB22D2206-SPE2DB25FJC73
- Not listed
- The Defense Logistics Agency awarded a $7,980.37 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be supplied from the vendor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded a delivery order valued at $45,565.02 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order, which is not set-aside, is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal healthcare systems to prevent blood clots...
- The Defense Logistics Agency awarded a delivery order valued at $10,329.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used for stroke prevention and blood clot treatment, representing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $15,735.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for ultimate completion by July 31, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely used...
- The Defense Logistics Agency awarded a delivery order valued at $3,011.76 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used primarily for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $18,853.79. This firm fixed-price delivery order, which is not set-aside, represents a continuation of pharmaceutical procurement under AmerisourceBergen's broader federal contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units, valued at $7,315.22. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract calls for delivery by August 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a anticoagulant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $12,612.95. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare settings for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order valued at $7,162.15 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, indicating...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,896.80 for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used to reduce stroke risk and treat blood clots, reflecting the Defense Logistics Agency...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC73Delivery Order
The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. Eliquis is a widely used anticoagulant medication prescribed to reduce the risk of stroke and blood clots in military and veteran healthcare populations. This delivery order is executed under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the contractor to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's continued participation in this prime vendor arrangement reflects its established capability to meet federal pharmaceutical procurement requirements through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.6k | 7/28/25 |